Toxic endpoints in the study of human exposure to environmental chemicals

Progress in Molecular Biology and Translational Science

Volumn 112, Issue , 2012, Pages 89-115

  Wallace, Andrew D ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866558314     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-415813-9.00004-0     Document Type: Chapter

References (94)

1. Hodgson E, Cuny H. Toxicity testing. In: Hodgson E, editor. A textbook of modern toxicology. 4th ed. Hoboken, NJ: John Wiley & Sons, Inc.; 2010. p. 409-56.
2. McKim Jr. JM. Building a tiered approach to in vitro predictive toxicity screening: a focus on assays with in vivo relevance. Comb Chem High Throughput Screen 2010;13:188-206.
3. Judson RS, Houck KA, Kavlock RJ, Knudsen TB, Martin MT, Mortensen HM, et al. In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project. Environ Health Perspect 2010;118:485-92.
4. Collins FS, Gray GM, Bucher JR. Toxicology. Transforming environmental health protection. Science 2008;319:906-7.
5. Smart RC, Ewing SJ, Loomis KD. Carcinogenesis. In: Smart RC, Hodgson E, editors. Molecular and biochemical toxicology. 4th ed. Hoboken, NJ: John Wiley & Sons, Inc.; 2008. p. 537-86.
6. Woolley A. Determination: genotoxicity and carcinogenicity. In: Woolley A, editor. A guide to practical toxicology evaluation, prediction, and risk. 2nd ed. New York, NY: Informa Healthcare USA, Inc.; 2008. p. 161-98.
7. Preston RJ. Genetic toxicology. In: Smart RC, Hodgson E, editors. Molecular and biochemical toxicology. 4th ed. Hoboken, NJ: John Wiley & Sons, Inc.; 2008. p. 587-606.
8. Boobis AR, Daston GP, Preston RJ, Olin SS. Application of key events analysis to chemical carcinogens and noncarcinogens. Crit Rev Food Sci Nutr 2009;49:690-707.
9. Preston RJ. Epigenetic processes and cancer risk assessment. Mutat Res 2007;616:7-10.
10. Karpinets TV, Foy BD. Tumorigenesis: the adaptation of mammalian cells to sustained stress environment by epigenetic alterations and succeeding matched mutations. Carci-nogenesis 2005;26:1323-34.
11. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007;128:683-92.
12. Pogribny IP, Rusyn I, Beland FA. Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: studies in rodents. Environ Mol Mutagen 2008;49:9-15.
13. Jacobson-Kram D, Sistare FD, Jacobs AC. Use of transgenic mice in carcinogenicity hazard assessment. Toxicol Pathol 2004;32(Suppl. 1):49-52.
14. Auerbach SS, Shah RR, Mav D, Smith CS, Walker NJ, Vallant MK, et al. Predicting the hepatocarcinogenic potential of alkenylbenzene flavoring agents using toxicogenomics and machine learning. Toxicol Appl Pharmacol 2010;243:300-14.
15. Hoenerhoff MJ, Pandiri AR, Lahousse SA, Hong HH, Ton TV, Masinde T, etal. Global gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancer. Toxicol Pathol 2011;39:678-99.
16. Cui Y, Paules RS. Use of transcriptomics in understanding mechanisms of drug-induced toxicity. Pharmacogenomics 2010;11:573-85.
17. Shah I, Houck K, Judson RS, Kavlock RJ, Martin MT, Reif DM, et al. Using nuclear receptor activity to stratify hepatocarcinogens. PLoS One 2011;6:e14584.
18. U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. Report on carcinogens, 12th ed. NTP; 2011.
19. Siemiatycki J, Richardson L, Straif K, Latreille B, Lakhani R, Campbell S, et al. Listing occupational carcinogens. Environ Health Perspect 2004;112:1447-59.
20. Alavanja MC, Hoppin JA, Kamel F. Health effects of chronic pesticide exposure: cancer and neurotoxicity. Annu Rev Public Health 2004;25:155-97.
21. Weichenthal S, Moase C, Chan P. A review of pesticide exposure and cancer incidence in the Agricultural Health Study cohort. Environ Health Perspect 2010;118:1117-25.
22. Wallace AD, Meyer SA. Hepatotoxicity. In: Smart RC, Hodgson E, editors. Molecular and biochemical toxicology. 4th ed. Hoboken, NJ: John Wiley and Sons, Inc.; 2008. p. 671-92.
23. Waring JF, Ciurlionis R, Jolly RA, Heindel M, Ulrich RG. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol Lett 2001;120:359-68.
24. Hamadeh HK, Bushel PR, Jayadev S, Martin K, DiSorbo O, Sieber S, et al. Gene expression analysis reveals chemical-specific profiles. Toxicol Sci 2002;67:219-31.
25. Maronpot RR, Yoshizawa K, Nyska A, Harada T, Flake G, Mueller G, et al. Hepatic enzyme induction: histopathology. Toxicol Pathol 2010;38:776-95.
26. Ennulat D, Walker D, Clemo F, Magid-Slav M, Ledieu D, Graham M, et al. Effects of hepatic drug-metabolizing enzyme induction on clinical pathology parameters in animals and man. Toxicol Pathol 2010;38:810-28.
27. Ovando BJ, Ellison CA, Vezina CM, Olson JR. Toxicogenomic analysis of exposure to TCDD, PCB126 and PCB153: identification of genomic biomarkers of exposure to AhR ligands. BMC Genomics 2010;11:583.
28. Goyak KM, Johnson MC, Strom SC, Omiecinski CJ. Expression profiling of interindividual variability following xenobiotic exposures in primary human hepatocyte cultures. Toxicol Appl Pharmacol 2008;231:216-24.
29. Bushel PR, Heinloth AN, Li J, Huang L, Chou JW, Boorman GA, et al. Blood gene expression signatures predict exposure levels. Proc Natl Acad Sci USA 2007;104:18211-6.
30. Manibusan MK, Odin M, Eastmond DA. Postulated carbon tetrachloride mode of action: a review. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2007;25:185-209.
31. Casabar RC, Das PC, Dekrey GK, Gardiner CS, Cao Y, Rose RL, et al. Endosulfan induces CYP2B6 and CYP3A4 by activating the pregnane X receptor. Toxicol Appl Pharmacol 2010;245:335-43.
32. Elefsiniotis IS, Liatsos GD, Stamelakis D, Moulakakis A. Case report: mixed cholestatic/ hepatocellular liver injury induced by the herbicide quizalofop-p-ethyl. Environ Health Perspect 2007;115:1479-81.
33. Hodgson E, Rose RL. Organophosphorus chemicals: potent inhibitors of the human metabolism of steroid hormones and xenobiotics. Drug Metab Rev 2006;38:149-62.
34. Hodgson E, Rose RL. Human metabolic interactions of environmental chemicals. J Biochem Mol Toxicol 2007;21:182-6.
35. Das PC, Cao Y, Roset RL, Cherrington N, Hodgson E. Enzyme induction and cyto-toxicity in human hepatocytes by chlorpyrifos and N, N-diethyl-m-toluamide (DEET). Drug Metabol Drug Interact 2008;23:237-60.
36. Das PC, Streit TM, Cao Y, Rose RL, Cherrington N, Ross MK, et al. Pyrethroids: cytotoxicity and induction of CYP isoforms in human hepatocytes. Drug Metabol Drug Interact 2008;23:211-36.
37. Hinson JA, Reid AB, McCullough SS, James LP. Acetaminophen-induced hepatotox-icity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metab Rev 2004;36:805-22.
38. Meier-Abt F, Faulstich H, Hagenbuch B. Identification of phalloidin uptake systems of rat and human liver. Biochim Biophys Acta 2004;1664:64-9.
39. Thiel C, Thiel K, Klingert W, Diewold A, Scheuermann K, Hawerkamp E, et al. The enterohepatic circulation of amanitin: kinetics and therapeutical implications. Toxicol Lett 2011;203:142-6.
40. Tarloff JB, Wallace AD. Biochemical mechanisms of renal toxicity. In: Smart R, Hodgson E, editors. Molecular and biochemical toxicology. 4th ed. New York: John Wiley and Sons, Inc.; 2008. p. 693-724.
41. Zhou Y, Vaidya VS, Brown RP, Zhang J, Rosenzweig BA, Thompson KL, et al. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci 2008;101:159-70.
42. Coca SG, Parikh CR. Urinary biomarkers for acute kidney injury: perspectives on translation. Clin J Am Soc Nephrol 2008;3:481-90.
43. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel im-munoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 1998;273:4135-42.
44. Bonventre JV. Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant 2009;24:3265-8.
45. Van Vleet TR, Schnellmann RG. Toxic nephropathy: environmental chemicals. Semin Nephrol 2003;23:500-8.
46. Zalups RK. Molecular interactions with mercury in the kidney. Pharmacol Rev 2000;52:113-43.
47. Bridges CC, Zalups RK. Molecular and ionic mimicry and the transport of toxic metals. Toxicol Appl Pharmacol 2005;204:274-308.
48. Brown CA, Jeong KS, Poppenga RH, Puschner B, Miller DM, Ellis AE, et al. Outbreaks of renal failure associated with melamine and cyanuric acid in dogs and cats in 2004 and 2007. J Vet Diagn Invest 2007;19:525-31.
49. Lebeau C, Debelle FD, Arlt VM, Pozdzik A, De Prez EG, Phillips DH, et al. Early proximal tubule injury in experimental aristolochic acid nephropathy: functional and histological studies. Nephrol Dial Transplant 2005;20:2321-32.
50. Pozdzik AA, Salmon IJ, Debelle FD, Decaestecker C, Van den Branden C, Verbeelen D, et al. Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int 2008;73:595-607.
51. Amin RP, Vickers AE, Sistare F, Thompson KL, Roman RJ, Lawton M, et al. Identification of putative gene-based markers of renal toxicity. Environ Health Perspect 2004;112:465-79.
52. Bonventre JV, Vaidya VS, Schmouder R, Feig P, Dieterle F. Next-generation biomarkers for detecting kidney toxicity. Nat Biotechnol 2010;28:436-40.
53. Hoffmann D, Adler M, Vaidya VS, Rached E, Mulrane L, Gallagher WM, et al. Performance of novel kidney biomarkers in preclinical toxicity studies. Toxicol Sci 2010;116:8-22.
54. Blake BL. Biochemical toxicology of the central nervous system. In: Hodgson E, editor. Molecular and biochemical toxicology. 4th ed. Hoboken, NJ: John Wiley and Sons, Inc.; 2008. p. 743-64.
55. Blake BL. Toxicology of the nervous system. In: Hodgson E, editor. A textbook of modern toxicology. 4th ed. Hoboken, NJ: John Wiley and Sons; 2010. p. 303-22.
56. Waller A. Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibres. Philos Trans R Soc London 1850;140:423-9.
57. Patisaul H. Reproductive system. In: Hodgson E, editor. A textbook of modern toxicology. 4th ed. Hoboken, NJ: John Wiley & Sons, Inc.; 2010. p. 323-43.
58. Woolley A. Determination: general and reproductive toxicology. In: Woolley A, editor. A guide to practical toxicology evaluation, prediction, and risk. New York, NY: Informa Healthcare USA, Inc.; 2008. p. 131-60.
59. Wilson VS, Lambright C, Furr J, Ostby J, Wood C, Held G, et al. Phthalate ester-induced gubernacular lesions are associated with reduced insl3 gene expression in the fetal rat testis. Toxicol Lett 2004;146:207-15.
60. Svechnikova I, Svechnikov K, Soder O. The influence of di-(2-ethylhexyl) phthalate on steroidogenesis by the ovarian granulosa cells of immature female rats. J Endocrinol 2007;194:603-9.
61. Bonde JP. Male reproductive organs are at risk from environmental hazards. Asian J Androl 2010;12:152-6.
62. Saiyed H, Dewan A, Bhatnagar V, Shenoy U, Shenoy R, Rajmohan H, et al. Effect of endosulfan on male reproductive development. Environ Health Perspect 2003;111:1958-62.
63. Goetz AK, Dix DJ. Mode of action for reproductive and hepatic toxicity inferred from a genomic study of triazole antifungals. Toxicol Sci 2009;110:449-62.
64. Goetz AK, Dix DJ. Toxicogenomic effects common to triazole antifungals and conserved between rats and humans. Toxicol Appl Pharmacol 2009;238:80-9.
65. Goetz AK, Ren H, Schmid JE, Blystone CR, Thillainadarajah I, Best DS, et al. Disruption of testosterone homeostasis as a mode of action for the reproductive toxicity of tri-azole fungicides in the male rat. Toxicol Sci 2007;95:227-39.
66. Bodwell JE, Gosse JA, Nomikos AP, Hamilton JW. Arsenic disruption of steroid receptor gene activation: complex dose-response effects are shared by several steroid receptors. Chem Res Toxicol 2006;19:1619-29.
67. Swan SH, Main KM, Liu F, Stewart SL, Kruse RL, Calafat AM, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 2005;113:1056-61.
68. Hauser R, Meeker JD, Duty S, Silva MJ, Calafat AM. Altered semen quality in relation to urinary concentrations of phthalate monoester and oxidative metabolites. Epidemiology 2006;17:682-91.
69. Hauser R, Meeker JD, Singh NP, Silva MJ, Ryan L, Duty S, et al. DNA damage in human sperm is related to urinary levels of phthalate monoester and oxidative metabolites. Hum Reprod 2006;22:688-95.
70. Craig ZR, Wang W, Flaws JA. Endocrine-disrupting chemicals in ovarian function: effects on steroidogenesis, metabolism and nuclear receptor signaling. Reproduction 2011;142:633-46.
71. White SS, Birnbaum LS. An overview of the effects of dioxins and dioxin-like compounds on vertebrates, as documented in human and ecological epidemiology. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2009;27:197-211.
72. Rider CV, Furr JR, Wilson VS, Gray LE. Cumulative effects of in utero administration of mixtures of reproductive toxicants that disrupt common target tissues via diverse mechanisms of toxicity. Int J Androl 2010;33:443-62.
73. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 2009;30:293-342.
74. LeBlanc GA. Endocrine toxicology. In: Hodgson E, editor. A textbook of modern toxicology. 4th ed. Hoboken, NJ: John Wiley & Sons; 2010. p. 345-62.
75. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs Jr. DR, Lee DH, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 2012;33:378-455.
76. Panganiban L, Cortes-Maramba N, Dioquino C, Suplido ML, Ho H, Francisco-Rivera A, et al. Correlation between blood ethylenethiourea and thyroid gland disorders among banana plantation workers in the Philippines. Environ Health Perspect 2004;112:42-5.
77. Flippin JL, Hedge JM, DeVito MJ, Leblanc GA, Crofton KM. Predictive modeling of a mixture of thyroid hormone disrupting chemicals that affect production and clearance of thyroxine. Int J Toxicol 2009;28:368-81.
78. Kashiwagi K, Furuno N, Kitamura S, Ohta S, Sugihara K, Utsumi K, et al. Disruption of thyroid hormone function by environmental pollutants. J Health Sci 2009;55:147-60.
79. Zhao B, Chu Y, Huang Y, Hardy DO, Lin S, Ge RS. Structure-dependent inhibition of human and rat 11beta-hydroxysteroid dehydrogenase 2 activities by phthalates. Chem Biol Interact 2010;183:79-84.
80. EPA, U.S. Endocrine Disruptor, Screening Program (EDSP); 2012.
81. Kaminski NE, Kaplan BLF, Holsapple MP. Toxic responses of the immune system. In: Klassen CD, editor. Casarett and Doull's toxicology: the basic sciences of poisons. 7th ed. New York, NY: McGraw-Hill Companies; 2008. p. 609-30.
82. Selgrade MK. Immune system. In: Hodgson E, editor. A textbook of modern toxicology. 4th ed. Hoboken, NJ: John Wiley & Sons, Inc.; 2010. p. 387-404.
83. Selgrade MK, Germolec DR, Luebke RW, Smialowicz RJ, Ward MD, Bowman CC. Immunotoxicity. In: Smart RC, Hodgson E, editors. Molecular and biochemical toxicology. 4th ed. Hoboken, NJ: John Wiley and Sons, Inc.; 2008. p. 765-803.
84. Anon. Immunosuppression. In: Hodgson E, Mailman RB, Chambers JE, editors. Dictionary of toxicology. London, UK: Macmillan Reference, Ltd.; 1998.
85. Nixon R, Frowen K, Moyle M. Occupational dermatoses. Aust Fam Physician 2005;34:327-33.
86. Kezic S, Visser MJ, Verberk MM. Individual susceptibility to occupational contact dermatitis. Ind Health 2009;47:469-78.
87. Fisseler-Eckhoff A, Bartsch H, Zinsky R, Schirren J. Environmental isocyanate-induced asthma: morphologic and pathogenetic aspects of an increasing occupational disease. Int J Environ Res Public Health 2011;8:3672-87.
88. Bonner JC. Respiratory toxicology. In: Smart RC, Hodgson E, editors. Molecular and biochemical toxicology. Hoboken, NJ: John Wiley & Sons, Inc.; 2008. p. 639-70.
89. Cooper GS, Makris SL, Nietert PJ, Jinot J. Evidence of autoimmune-related effects of trichloroethylene exposure from studies in mice and humans. Environ Health Perspect 2009;117:696-702.
90. Pollard KM, Hultman P, Kono DH. Toxicology of autoimmune diseases. Chem Res Toxicol 2010;23:455-66.
91. Burek CL, Talor MV. Environmental triggers of autoimmune thyroiditis. J Autoimmun 2009;33:183-9.
92. Thayer KA, KA Heindel JJ, Bucher JR, Gallo MA. Role of environmental chemicals in diabetes and obesity: a national toxicology program workshop report.. Environ Health Perspect 2012;120:779-89.
93. Van Loveren H, Piersma A. Immunotoxicological consequences of perinatal chemical exposures. Toxicol Lett 2004;149:141-5.
94. Colosio C, Birindelli S, Corsini E, Galli CL, Maroni M. Low level exposure to chemicals and immune system. Toxicol Appl Pharmacol 2005;207:320-8.